NM_006610.4(MASP2):c.1111G>T (p.Asp371Tyr) AND not specified

Germline classification:: Benign (1 submission)
Last evaluated:: Mar 29, 2016
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000454761.4

Allele description [Variation Report for NM_006610.4(MASP2):c.1111G>T (p.Asp371Tyr)]

NM_006610.4(MASP2):c.1111G>T (p.Asp371Tyr)

Gene:

MASP2:MBL associated serine protease 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1p36.22

Genomic location:

Preferred name:

NM_006610.4(MASP2):c.1111G>T (p.Asp371Tyr)

HGVS:

NC_000001.11:g.11030859C>A
NG_007289.2:g.21370G>T
NM_006610.4:c.1111G>TMANE SELECT
NP_006601.2:p.Asp371Tyr
LRG_82t1:c.1111G>T
LRG_82:g.21370G>T
LRG_82p1:p.Asp371Tyr
NC_000001.10:g.11090916C>A
NM_006610.3:c.1111G>T
O00187:p.Asp371Tyr

Protein change:

D371Y

Links:

UniProtKB: O00187#VAR_028785; dbSNP: rs12711521

NCBI 1000 Genomes Browser:

rs12711521

Molecular consequence:

NM_006610.4:c.1111G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

PREDICTED: Danio rerio UPF1 RNA helicase and ATPase (upf1), transcript variant X...
PREDICTED: Danio rerio UPF1 RNA helicase and ATPase (upf1), transcript variant X1, mRNA
gi|2800564702|ref|XM_005163640.5|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000539590	Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	criteria provided, single submitter (LMM Criteria)	Benign (Mar 29, 2016)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000539590

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

criteria provided, single submitter

(LMM Criteria)

Benign
(Mar 29, 2016)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]

PMID:: 24033266
PMCID:: PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000539590.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine